The present data indicating the involvement of the classical pathway in intra-tumoral androgen/estrogen synthesis points to an additional new mechanism in growth and development of ER+/PR+ breast and/or other pertinent cancers, even though overexpression of aromatase, resulting in an increase in estrogen synthesis through the non-classical pathway is well established. The gene discussed is ESR1; the disease is cancer.